Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Dermatol Res ; 316(7): 482, 2024 Jul 23.
Article in English | MEDLINE | ID: mdl-39042316

ABSTRACT

BACKGROUND: In the absence of a gold-standard diagnostic modality for cellulitis, sterile inflammatory disorders may be misdiagnosed as cellulitis. OBJECTIVE: To determine the utility of skin biopsy and tissue culture for the diagnosis and management of patients admitted with a diagnosis of presumed cellulitis. DESIGN: Pilot single-blind parallel group randomized controlled clinical trial in 56 patients with a primary diagnosis of presumed cellulitis. In the intervention group only, skin biopsy and tissue culture results were made available to the primary care team to guide diagnosis and management. Length of hospital stay and antibiotic use were evaluated as outcome measures. RESULTS: Length of stay showed the greatest opportunity for further study as a primary outcome (intervention: 4, IQR (2-6) vs. control: 5 IQR (3-8) days; p = 0.124). LIMITATIONS: The COVID-19 pandemic placed limitations on participant enrollment and study duration; in addition, data was collected from a single medical center. CONCLUSION: This study demonstrates that length of stay and anti-pseudomonal antibiotic de-escalation are endpoints that may be influenced by biopsy and tissue culture results in presumed cellulitis patients; these outcomes warrant further study.


Subject(s)
Anti-Bacterial Agents , COVID-19 , Cellulitis , Length of Stay , Humans , Cellulitis/diagnosis , Cellulitis/drug therapy , Cellulitis/pathology , Female , Male , Middle Aged , Length of Stay/statistics & numerical data , Biopsy , Pilot Projects , Anti-Bacterial Agents/therapeutic use , Single-Blind Method , Adult , Aged , Skin/pathology , Skin/microbiology , Tissue Culture Techniques , SARS-CoV-2 , Inpatients/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL